Form 4 for IMMX Immix Biopharma, Inc.
Accepted 2026-05-29 17:05:23 ET · period of report 2026-05-22 · accession 0001493152-26-026427 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-29 17:05 | 2026-05-22 | IMMX | Marquet Magda | Dir | A - Grant | $0.00 | +6,250 | 52.3K | +14% | $0 |
| D | 2026-05-29 17:05 | 2026-05-22 | IMMX | Marquet Magda | Dir | A - Grant | $0.00 | +12.5K | 12.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-22 | A | A | 6,250 | $0.00 | 52,342 | D | — | — | (F1) The Reporting Person was granted 6,250 restricted stock units ("RSUs") pursuant to the Issuer's 2021 Equity Incentive Plan, which RSUs will vest in full on the earlier of (i) the one-year anniversary of the date of grant, and (ii) the date that the Issuer's 2027 annual meeting of stockholders (the "2027 Annual Meeting") is held, subject to the Reporting Person's continued service with the Issuer. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-05-22 | A | A | 12,500 | $0.00 | 12,500 | D | $8.78 · — to 2036-05-22 | 12,500 Common Stock | (F3) The stock option will vest in substantially equal monthly installments over the 12 months following the date of grant (or, in the event the 2027 Annual Meeting occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the stock option will vest on the date of such 2027 Annual Meeting), subject to the Reporting Person's continued service on the Issuer's Board through the applicable vesting date. |